Alternative tobacco bill in Senate
This article was originally published in The Tan Sheet
Executive Summary
Sen. Richard Burr, R-N.C., introduces the Federal Tobacco Bill, S. 579, to establish an agency to regulate the manufacture, marketing and use of tobacco products under the Department of Health and Human Services. The legislation is similar to the Youth Prevention and Tobacco Harm Reduction Act, H.R. 1261, introduced March 3 by Rep. Steve Buyer, R-Ind. (1"The Tan Sheet" March 9, 2009, p. 3). During an Energy and Commerce Committee markup March 4, Buyer touted his tobacco bill as an alternative to Chairman Henry Waxman's, D-Calif., Family Smoking Prevention and Tobacco Control Act, H.R. 1256, which would make tobacco an FDA-regulated product. Waxman's bill passed the committee and will move to a floor vote
You may also be interested in...
Tobacco Oversight Looks More Likely, But Is It Bad For FDA’s Health?
The likelihood of Congress handing FDA responsibility for regulating tobacco has ignited debate over whether the new purview would distract an already struggling agency from its mission
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.